Skip to content

Microsoft’s MAI-DxO AI outperforms doctors in diagnostics, Windows Defender matches paid antivirus

Microsoft’s artificial intelligence advancements are making headlines on two fronts: its MAI-DxO diagnostic system has demonstrated superior accuracy compared to generalist physicians in complex medical cases, while Windows Defender Antivirus now rivals paid third-party security suites. These developments signal shifts in both healthcare technology and consumer cybersecurity.

Editor, Lazyfounder

Published 4 min read
Microsoft’s MAI-DxO AI outperforms doctors in diagnostics, Windows Defender matches paid antivirus
Image: Engadget via source

Windows Defender’s evolution closes the gap with paid antivirus

Since Windows 8 launched in 2012, Microsoft has included built-in antivirus protection through Microsoft Defender Antivirus. Early versions scored poorly—just 0.5 out of 6 in AV-Test’s 2015 protection quality evaluations—but by 2026, it achieved a perfect score of 6. This improvement reflects years of refinement, making it a silent but effective default option for most users.

Paid antivirus suites like McAfee, Norton, and AVG still bundle extras such as VPNs, password managers, and cloud storage. However, tests show these features often go unused, and third-party software can slow PC performance during full scans. Installing such suites also disables Microsoft Defender to avoid conflicts, leaving users reliant on a single vendor’s protection.

Microsoft Defender operates quietly, only alerting users when threats are detected. Browser-based protections like Microsoft Edge’s SmartScreen add another layer of defense at no additional cost. For most users, this combination reduces the need for paid alternatives, though exceptions may remain for high-risk scenarios.

MAI-DxO achieves breakthrough accuracy in medical diagnostics

Microsoft’s AI Diagnostic Orchestrator (MAI-DxO) system outperformed generalist physicians in diagnosing complex medical cases, achieving 83.2% accuracy compared to 36.1% for doctors with access to reference materials. In emergency department scenarios, MAI-DxO reached 80.3% accuracy, nearly doubling the 46.8% rate of physicians. The system simulates a panel of doctors by coordinating multiple AI agents that question patients, order tests, and debate diagnoses sequentially.

The strongest results came from OpenAI’s GPT-5 and GPT-5.5 models, though Microsoft tested versions with Google’s Gemini 2.5 Flash, Anthropic, Meta, and DeepSeek. DxO reduced costs and the number of tests required for complex cases, though its advantages were less pronounced in simpler emergency scenarios. A paper detailing these findings, originally posted on arXiv in 2025, was published in the peer-reviewed journal Science in October 2026.

Microsoft defines its goal as "medical superintelligence"—surpassing human-led health systems in reasoning and care coordination. Clinical testing will begin at Boston’s Beth Israel Deaconess Medical Center within the next two months, with a broader partnership with Mayo Clinic underway to train a healthcare-specific foundation model for release next year.

Limitations and caution around AI diagnostics

While MAI-DxO’s accuracy is striking, experts emphasize that AI systems are not intended to replace human doctors. Instead, they are positioned as assistants to improve diagnostic speed and reduce costs. Legal and ethical questions remain about accountability when AI-assisted diagnoses go wrong, as highlighted by a 2025 study where doctors’ performance declined after relying on AI for cancer detection.

The system’s cost savings are based on simulations, not real-world medical billing. Researchers also propose a new benchmark, the Sequential Diagnosis Benchmark (SDBench), to evaluate large language models’ diagnostic capabilities. These tools may reshape medical training and workflows but will require rigorous validation before widespread adoption.

What this means

Lazyfounder analysis — our interpretation, not reported fact.

For founders and operators, Microsoft’s progress in AI diagnostics and cybersecurity carries distinct implications. The leap in MAI-DxO’s accuracy—particularly its ability to outperform physicians in complex cases—signals opportunities for startups building AI-assisted clinical tools. However, the system’s reliance on OpenAI’s latest models underscores the competitive advantage enjoyed by companies with access to cutting-edge language models. Founders in healthcare tech should note the emphasis on collaboration with human doctors rather than replacement, a model that may define regulatory and adoption pathways.

Meanwhile, Windows Defender’s parity with paid antivirus suites could pressure vendors like Norton and McAfee to justify their pricing or pivot toward enterprise and niche use cases. For startups in cybersecurity, this shift may open doors for value-added services layered on top of Defender, such as advanced threat detection for high-risk industries or integration with zero-trust architectures. The broader trend—Windows providing robust, no-cost security—mirrors Microsoft’s strategy in other areas, like bundling Teams with Office, and could foreshadow similar moves in other product categories.

Sources

  1. Engadget · 2026-10-19
    Is Paid Antivirus Actually A Waste Of Money For Your PC In 2026?
  2. TechCrunch · 2026-10-22
    Microsoft’s Mustafa Suleyman says its AI outperforms doctors on hard cases as he chases ‘medical superintelligence’
  3. Gizmodo · 2026-10-22
    Microsoft Says Its New AI Is More Than Twice as Good at Diagnosing Diseases as Doctors

This story is an original summary drafted with AI by Lazyfounder from the reporting listed above and checked by automated validation. Facts are attributed to their original publishers; sections marked as analysis are Lazyfounder's. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links, and see our AI policy and corrections policy.

About the author

Editor, Lazyfounder

Tarun Mottlia edits LazyFounders, covering Indian startups, funding rounds, AI and product launches. Every story on the site is AI-assisted and checked against its cited sources before publication.

More stories by Tarun Mottlia

Get the LazyFounder Brief

Startup, funding and AI news in a five-minute read. Join the early-access list.

Lazy Founder - Powered by Blogy.in

Contact us

Have a story tip, correction or partnership idea?

Write to us at tarun.kumar@blogy.in or talk to the founder directly. We read every message.

Contact us